Background
Increased sympathetic outflow is a major contributor to the progression of chronic heart failure (CHF). Potentiation of glutamatergic tone has been causally related to the sympathoexcitation in CHF. Specifically, an increase in the N-methyl-D-aspartate-type1 receptor (NMDA-NR1) expression within the paraventricular nucleus (PVN) is critically linked to the increased sympathoexcitation during CHF. However, the molecular mechanism(s) for the up-regulation of NMDA-NR1 remains unexplored. We hypothesized that hypoxia via HIF-1α might contribute to the augmentation of the NMDA-NR1 mediated sympathoexcitatory responses from the PVN in CHF.
Methods and Results
Immunohistochemistry staining, mRNA, and protein for hypoxia-inducible-factor 1α (HIF-1α) were up-regulated within the PVN of left coronary artery ligated CHF rats. In neuronal cell line (NG108-15) in vitro, hypoxia caused a significant increase in mRNA as well as protein for HIF-1α (2-fold) with the concomitant increase in NMDA-NR1 mRNA, protein levels, as well as glutamate-induced Ca+ influx. ChIP assay identified HIF-1α binding to NMDA-NR1 promoter during hypoxia. Silencing of HIF-1α in NG108 cells leads to a significant decrease in expression of NMDA-NR1 suggesting that expression of HIF-1α is necessary for the upregulation of NMDA-NR1. Consistent with these observations, HIF-1α silencing within the PVN abrogated the increased basal sympathetic tone as well as sympathoexcitatory responses to microinjection of NMDA in the PVN of rats with CHF.
Conclusions
These results uncover a critical role for HIF-1 in the up-regulation of NMDA-NR1 to mediate sympathoexcitation in CHF. We conclude that subtle hypoxia within the PVN may act as a metabolic cue to modulate sympathoexcitation during CHF.